(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SKYCOVID19

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SKYCOVID19

ST13

US500000079301874

Class

5

Filing

79301874

Registration

6465891

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

11/27/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

10/14/2020

Registration date

08/31/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/31/2021

Last transaction

11/27/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

LOOK, JEFFREY

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SK bioscience Co., Ltd.

Representatives

Hun Joon Kim LEX IP Meister, PLLC.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary preparations for use in the treatment or prevention of Covid-19; drugs for medical purposes for use in the treatment or prevention of Covid-19; pharmaceuticals for use in the treatment or prevention of Covid-19; Vaccinesveterinary vaccinesviral vaccineshuman vaccine preparationsvaccines against pneumococcal infections with all of the aforementioned for use in connection with the treatment or prevention of Covid-19; diagnostic reagents for medical use in connection with immunization against Covid-19; diagnostic agents for pharmaceutical use for diagnosing Covid-19; pharmaceutical products for the treatment of infectious diseasesCovid-19; pharmaceutical products for the treatment of viral diseasesCovid-19; antiviral preparations for use in the connection with the treatment or prevention of Covid-19; immunotherapeutic agents for medical use related to the treatment bacterial infections from Covid-19; bacterial preparations for medical purposes for use in connection with the treatment of condition related to Covid-19; reagents for use in diagnostic tests for medical purposes for purposes of diagnosing Covid-19 infections; sterilizing washes for use in preventing the transmission of Covid-19; disinfectants for chemical toilets for use in preventing the transmission of Covid-19; medical diagnostic test strips for use in connection with diagnosing Covid-19 infections

Publications

History of USPTO decisions and trademark events.

26 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/27/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/27/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/27/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/27/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/07/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/10/2022

FIMP

FINAL DISPOSITION PROCESSED

02/10/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/30/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/31/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/15/2021

PUBO

PUBLISHED FOR OPPOSITION

06/15/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/26/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/07/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/30/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/29/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/29/2021

RFNT

REFUSAL PROCESSED BY IB

04/25/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/05/2021

RFRR

REFUSAL PROCESSED BY MPU

04/05/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/30/2021

CNRT

NON-FINAL ACTION WRITTEN

03/29/2021

DOCK

ASSIGNED TO EXAMINER

03/24/2021

DOCK

ASSIGNED TO EXAMINER

03/15/2021

MAFR

APPLICATION FILING RECEIPT MAILED

01/12/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/08/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/07/2021

Continuous trademark protection

Get notified about every new filing that threatens SKYCOVID19 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.